These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 27712122)
1. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling. Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122 [TBL] [Abstract][Full Text] [Related]
2. Relationship between circulating visfatin/NAMPT, nutritional status and insulin resistance in an elderly population - results from the PolSenior substudy. Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J Metabolism; 2014 Nov; 63(11):1409-18. PubMed ID: 25172122 [TBL] [Abstract][Full Text] [Related]
3. Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly - results from the PolSenior substudy. Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J J Am Soc Hypertens; 2015 Jan; 9(1):1-8. PubMed ID: 25537462 [TBL] [Abstract][Full Text] [Related]
4. Elevated visfatin levels in obese children are related to proinflammatory factors. Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785 [TBL] [Abstract][Full Text] [Related]
5. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats. Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420 [TBL] [Abstract][Full Text] [Related]
6. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes. Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014 [TBL] [Abstract][Full Text] [Related]
7. Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Oki K; Yamane K; Kamei N; Nojima H; Kohno N Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078 [TBL] [Abstract][Full Text] [Related]
8. Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration in elderly subjects with metabolic syndrome. Kocełak P; Olszanecka-Glinianowicz M; Owczarek AJ; Krupa W; Obirek P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Skalska A; Więcek A; Chudek J Pol Arch Med Wewn; 2015; 125(6):402-13. PubMed ID: 25924024 [TBL] [Abstract][Full Text] [Related]
9. Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration is not related to kidney function in elderly subjects. Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bozentowicz-Wikarek M; Brzozowska A; Mossakowska M; Skalska A; Wiecek A; Chudek J Clin Chem Lab Med; 2015 Apr; 53(5):793-9. PubMed ID: 25274953 [TBL] [Abstract][Full Text] [Related]
10. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females. Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161 [TBL] [Abstract][Full Text] [Related]
11. Differential significance of plasma visfatin concentrations according to adiposity in children and adolescents. Kim HJ; Park SY; Choi YJ; Han SJ; Lee KW; Kim DJ Horm Res Paediatr; 2013; 79(4):208-13. PubMed ID: 23615041 [TBL] [Abstract][Full Text] [Related]
12. The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Wang P; van Greevenbroek MM; Bouwman FG; Brouwers MC; van der Kallen CJ; Smit E; Keijer J; Mariman EC Pflugers Arch; 2007 Sep; 454(6):971-6. PubMed ID: 17429683 [TBL] [Abstract][Full Text] [Related]
13. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome. Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377 [TBL] [Abstract][Full Text] [Related]
14. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids. Chang YC; Chang TJ; Lee WJ; Chuang LM Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775 [TBL] [Abstract][Full Text] [Related]
15. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors. Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978 [TBL] [Abstract][Full Text] [Related]
16. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients. Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156 [TBL] [Abstract][Full Text] [Related]
17. Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case-control study. Akdogan N; Alli N; Uysal PI; Topcuoglu C; Candar T; Turhan T Arch Dermatol Res; 2018 Dec; 310(10):785-793. PubMed ID: 30293125 [TBL] [Abstract][Full Text] [Related]
18. Body fat distribution has no effect on serum visfatin levels in healthy female subjects. Ersoy C; Sadikoglu G; Orhan H; Guclu M; Sarandol E; Akgun MD; Ozcakir A; Imamoglu S Cytokine; 2010 Mar; 49(3):275-8. PubMed ID: 20045351 [TBL] [Abstract][Full Text] [Related]
19. Serum concentration of visfatin in obese women. Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P; Semik-Grabarczyk E; Holecki M; Dabrowski P; Skorupa A Metabolism; 2007 Aug; 56(8):1131-4. PubMed ID: 17618961 [TBL] [Abstract][Full Text] [Related]
20. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models. Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]